Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Mavacamten in Patients With Symptomatic Latent Obstructive Hypertrophic Cardiomyopathy: A Randomized Controlled Trial

NCT06947590 is registered in ClinicalTrials.gov with Xu Liu as lead sponsor.

NCT NCT06947590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06947590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Mavacamten in Patients With Symptomatic Latent Obstructive Hypertrophic Cardiomyopathy: A Randomized Controlled Trial
Lead sponsor
Xu Liu
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 20, 2025
Completion date
February 1, 2026
Enrollment
78 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hcm - hypertrophic cardiomyopathy, mavacamten